Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-021550
Filing Date
2012-04-03
Accepted
2012-04-03 14:23:26
Documents
1
Period of Report
2012-04-02

Document Format Files

Seq Description Document Type Size
1 rrd336627.html 3  
1 rrd336627.xml 3 1587
  Complete submission text file 0001181431-12-021550.txt   2891
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address
Johnson David Louis (Reporting) CIK: 0001352238 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 12736859